How can sponsors gather postmarket data on pregnant women? When would sponsors need a pregnancy exposure registry as opposed to another collection method, and how should a pregnancy exposure registry be designed? Those questions were the topic of a recent FDAnews webinar on developing innovative approaches to collecting postmarketing safety data in pregnant women.
Source: Clinical Trials Advisor